Vimarsana
Biggest News Aggregation in the World

Roche Ventana News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Ventana. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Ventana Today - Breaking & Trending Today

ImmunoGen, Takeda Partner to Develop Ovarian Cancer Drug in Japan - Vimarsana News

ImmunoGen, Takeda Partner to Develop Ovarian Cancer Drug in Japan

Takeda will develop and commercialize ImmunoGen's antibody-drug conjugate Elahere in Japan as a treatment for FRα-positive ovarian cancer.

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases - Vimarsana News

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases

Seed round co-led by Wellington Partners and Forbion, with non-dilutive funding from BMBF GO-Bio enables maturation of platform and pipeline towards first clinical evaluation Seamless Therapeutics

$5.1 Billion Histology and Cytology In Vitro Diagnostics (IVD) Market, reports Kalorama Information - Vimarsana News

$5.1 Billion Histology and Cytology In Vitro Diagnostics (IVD) Market, reports Kalorama Information

Arlington, VA (PRWEB) November 10, 2022 -- The market for the testing of tissues and cells, histology and cytology in vitro diagnostics reached $4.9 billion

Source: prweb.com
Aignostics Raises €14m Series A to Advance AI-powered Pathology - Vimarsana News

Aignostics Raises €14m Series A to Advance AI-powered Pathology

Oversubscribed financing round with top-tier life science investors, led by Wellington Partners Spin-off from Charité – Universitätsmedizin Berlin developing

Aignostics Raises €14m Series A to Advance AI-powered - Vimarsana News

Aignostics Raises €14m Series A to Advance AI-powered

Oversubscribed financing round with top-tier life science investors, led by Wellington PartnersSpin-off from Charité – Universitätsmedizin Berlin...